晚期胰腺癌-话题@MedSci

#晚期胰腺癌#

34篇内容 | 2443人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1389568, encodeId=c3ae138956856, content=<a href='/topic/show?id=82a95988106' target=_blank style='color:#2F92EE;'>#晚期胰腺癌#</a>, objectTitle=晚期胰腺癌介入治疗临床操作指南(试行) （第三版）, objectType=article, longId=162000, objectId=d0481620009e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d0481620009e, replyNumber=0, likeNumber=58, createdTime=2019-03-11, rootId=0, userName=ms7899726347904398, userId=fdd32500040, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d0481620009e, moduleTitle=晚期胰腺癌介入治疗临床操作指南(试行) （第三版）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d0481620009e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1389567, encodeId=d1ee138956e81, content=<a href='/topic/show?id=82a95988106' target=_blank style='color:#2F92EE;'>#晚期胰腺癌#</a>, objectTitle=Tyme获得FDA关于SM-88治疗晚期胰腺癌的指导 , objectType=article, longId=161244, objectId=37f6161244e8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=37f6161244e8, replyNumber=0, likeNumber=117, createdTime=2019-02-28, rootId=0, userName=ms7899726347904398, userId=fdd32500040, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=37f6161244e8, moduleTitle=Tyme获得FDA关于SM-88治疗晚期胰腺癌的指导 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=37f6161244e8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1389566, encodeId=9b93138956612, content=<a href='/topic/show?id=82a95988106' target=_blank style='color:#2F92EE;'>#晚期胰腺癌#</a>, objectTitle=晚期胰腺癌介入治疗临床操作指南( 试行) ( 第二版), objectType=article, longId=131397, objectId=7fca13139edf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7fca13139edf, replyNumber=0, likeNumber=37, createdTime=2018-03-05, rootId=0, userName=ms7899726347904398, userId=fdd32500040, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7fca13139edf, moduleTitle=晚期胰腺癌介入治疗临床操作指南( 试行) ( 第二版), moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7fca13139edf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1389565, encodeId=f22e1389565da, content=<a href='/topic/show?id=82a95988106' target=_blank style='color:#2F92EE;'>#晚期胰腺癌#</a>, objectTitle=CLIN CANCER RES：DC-CIK免疫治疗联合S-1化疗治疗晚期胰腺癌, objectType=article, longId=112231, objectId=c53111223176, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c53111223176, replyNumber=0, likeNumber=65, createdTime=2017-09-09, rootId=0, userName=ms7899726347904398, userId=fdd32500040, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c53111223176, moduleTitle=CLIN CANCER RES：DC-CIK免疫治疗联合S-1化疗治疗晚期胰腺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c53111223176)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1389564, encodeId=a8e51389564db, content=<a href='/topic/show?id=82a95988106' target=_blank style='color:#2F92EE;'>#晚期胰腺癌#</a>, objectTitle=SCI REP：治疗前的C-反应蛋白与白蛋白比值可以预测晚期胰腺癌患者的总体生存期！, objectType=article, longId=101094, objectId=fe6610109450, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fe6610109450, replyNumber=0, likeNumber=75, createdTime=2017-06-09, rootId=0, userName=ms7899726347904398, userId=fdd32500040, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fe6610109450, moduleTitle=SCI REP：治疗前的C-反应蛋白与白蛋白比值可以预测晚期胰腺癌患者的总体生存期！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fe6610109450)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1389563, encodeId=16f01389563e5, content=<a href='/topic/show?id=82a95988106' target=_blank style='color:#2F92EE;'>#晚期胰腺癌#</a>, objectTitle=晚期胰腺癌介入治疗临床操作指南（试行）, objectType=article, longId=84340, objectId=c32c8434087, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c32c8434087, replyNumber=0, likeNumber=44, createdTime=2016-12-16, rootId=0, userName=ms7899726347904398, userId=fdd32500040, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c32c8434087, moduleTitle=晚期胰腺癌介入治疗临床操作指南（试行）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c32c8434087)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1389562, encodeId=41f6138956245, content=<a href='/topic/show?id=82a95988106' target=_blank style='color:#2F92EE;'>#晚期胰腺癌#</a>, objectTitle=JAMA：对于局部晚期胰腺癌，化放疗并不优于单独化疗治疗, objectType=article, longId=67543, objectId=f5586e54363, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f5586e54363, replyNumber=0, likeNumber=48, createdTime=2016-05-06, rootId=0, userName=ms7899726347904398, userId=fdd32500040, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f5586e54363, moduleTitle=JAMA：对于局部晚期胰腺癌，化放疗并不优于单独化疗治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f5586e54363)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1389561, encodeId=d5b21389561dd, content=<a href='/topic/show?id=82a95988106' target=_blank style='color:#2F92EE;'>#晚期胰腺癌#</a>, objectTitle=Plos One：PDX可用作晚期胰腺癌理想研究模型, objectType=article, longId=59080, objectId=3820590800a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3820590800a, replyNumber=0, likeNumber=83, createdTime=2015-11-21, rootId=0, userName=ms7899726347904398, userId=fdd32500040, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3820590800a, moduleTitle=Plos One：PDX可用作晚期胰腺癌理想研究模型, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3820590800a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1389560, encodeId=f01d13895600d, content=<a href='/topic/show?id=82a95988106' target=_blank style='color:#2F92EE;'>#晚期胰腺癌#</a>, objectTitle=Clin Cancer Res：帕尼单抗联合吉西他滨放化疗用于局部晚期胰腺癌的I期临床研究, objectType=article, longId=52061, objectId=5d9d520619e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5d9d520619e, replyNumber=0, likeNumber=110, createdTime=2015-06-15, rootId=0, userName=ms7899726347904398, userId=fdd32500040, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5d9d520619e, moduleTitle=Clin Cancer Res：帕尼单抗联合吉西他滨放化疗用于局部晚期胰腺癌的I期临床研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5d9d520619e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1389559, encodeId=89a8138955936, content=<a href='/topic/show?id=82a95988106' target=_blank style='color:#2F92EE;'>#晚期胰腺癌#</a>, objectTitle=Lancet：二甲双胍不能改善晚期胰腺癌患者的治疗结果, objectType=article, longId=51867, objectId=336d5186ea4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=336d5186ea4, replyNumber=0, likeNumber=71, createdTime=2015-06-11, rootId=0, userName=ms7899726347904398, userId=fdd32500040, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=336d5186ea4, moduleTitle=Lancet：二甲双胍不能改善晚期胰腺癌患者的治疗结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=336d5186ea4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1389558, encodeId=e8281389558cb, content=<a href='/topic/show?id=82a95988106' target=_blank style='color:#2F92EE;'>#晚期胰腺癌#</a>, objectTitle=ASCO GI 2014：两种胰腺癌疫苗序贯应用对晚期胰腺癌疗效良好, objectType=article, longId=30062, objectId=ee7c300622b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ee7c300622b, replyNumber=0, likeNumber=96, createdTime=2014-01-28, rootId=0, userName=ms7899726347904398, userId=fdd32500040, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ee7c300622b, moduleTitle=ASCO GI 2014：两种胰腺癌疫苗序贯应用对晚期胰腺癌疗效良好, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ee7c300622b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1389557, encodeId=cfd4138955ec5, content=<a href='/topic/show?id=82a95988106' target=_blank style='color:#2F92EE;'>#晚期胰腺癌#</a>, objectTitle=刘云鹏教授：晚期胰腺癌的治疗方案探索, objectType=article, longId=9354, objectId=edb393549d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=edb393549d, replyNumber=0, likeNumber=80, createdTime=2012-08-30, rootId=0, userName=ms7899726347904398, userId=fdd32500040, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=edb393549d, moduleTitle=刘云鹏教授：晚期胰腺癌的治疗方案探索, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=edb393549d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1389556, encodeId=5bff1389556e0, content=<a href='/topic/show?id=82a95988106' target=_blank style='color:#2F92EE;'>#晚期胰腺癌#</a>, objectTitle=Annals Oncol：吉西他滨联合索拉非尼治疗不改善晚期胰腺癌患者PFS, objectType=article, longId=7834, objectId=d7eee83466, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d7eee83466, replyNumber=0, likeNumber=78, createdTime=2012-07-15, rootId=0, userName=ms7899726347904398, userId=fdd32500040, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d7eee83466, moduleTitle=Annals Oncol：吉西他滨联合索拉非尼治疗不改善晚期胰腺癌患者PFS, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d7eee83466)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1389555, encodeId=a682138955591, content=<a href='/topic/show?id=82a95988106' target=_blank style='color:#2F92EE;'>#晚期胰腺癌#</a>, objectTitle=晚期胰腺癌一线治疗进展, objectType=article, longId=3226, objectId=87b8322658, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=87b8322658, replyNumber=0, likeNumber=89, createdTime=2011-10-22, rootId=0, userName=ms7899726347904398, userId=fdd32500040, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=87b8322658, moduleTitle=晚期胰腺癌一线治疗进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=87b8322658)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

晚期胰腺癌

2020-05-29

ms7899726347904398

#晚期胰腺癌#

晚期胰腺癌介入治疗临床操作指南(试行) （第三版）

2019-03-11

ms7899726347904398

#晚期胰腺癌#

Tyme获得FDA关于SM-88治疗晚期胰腺癌的指导 

2019-02-28

ms7899726347904398

#晚期胰腺癌#

晚期胰腺癌介入治疗临床操作指南( 试行) ( 第二版)

2018-03-05

ms7899726347904398

#晚期胰腺癌#

CLIN CANCER RES：DC-CIK免疫治疗联合S-1化疗治疗晚期胰腺癌

2017-09-09

ms7899726347904398

#晚期胰腺癌#

SCI REP：治疗前的C-反应蛋白与白蛋白比值可以预测晚期胰腺癌患者的总体生存期！

2017-06-09

ms7899726347904398

#晚期胰腺癌#

晚期胰腺癌介入治疗临床操作指南（试行）

2016-12-16

ms7899726347904398

#晚期胰腺癌#

JAMA：对于局部晚期胰腺癌，化放疗并不优于单独化疗治疗

2016-05-06

ms7899726347904398

#晚期胰腺癌#

Plos One：PDX可用作晚期胰腺癌理想研究模型

2015-11-21

ms7899726347904398

#晚期胰腺癌#

Clin Cancer Res：帕尼单抗联合吉西他滨放化疗用于局部晚期胰腺癌的I期临床研究

2015-06-15

ms7899726347904398

#晚期胰腺癌#

Lancet：二甲双胍不能改善晚期胰腺癌患者的治疗结果

2015-06-11

ms7899726347904398

#晚期胰腺癌#

ASCO GI 2014：两种胰腺癌疫苗序贯应用对晚期胰腺癌疗效良好

2014-01-28

ms7899726347904398

#晚期胰腺癌#

刘云鹏教授：晚期胰腺癌的治疗方案探索

2012-08-30

ms7899726347904398

#晚期胰腺癌#

Annals Oncol：吉西他滨联合索拉非尼治疗不改善晚期胰腺癌患者PFS

2012-07-15

ms7899726347904398

#晚期胰腺癌#

晚期胰腺癌一线治疗进展

2011-10-22

科室
- - 订阅+
  - 更多科室
工具
服务